Efficient plastic waste degradation with tuneable catalytic nanocomposites
Advanced catalytic nanocomposites for efficient plastic waste degradation offer enhanced lifespan, selectivity, and environmental benefits. This solution focuses on upcycling HDPE into wax using multi-metallic nanoceramics with tuneable selectivity, maximizing efficiency and minimizing by-products.
Overview
This innovative solution utilizes advanced catalytic nanocomposites to efficiently degrade plastic waste, specifically focusing on the upcycling of HDPE into wax. By addressing the common issues of catalyst lifespan and selectivity, the technology offers a more sustainable and efficient approach to plastic waste management. The key innovation lies in the use of non-toxic, multi-metallic nanoceramics embedded on a functional support, ensuring enhanced durability and tuneable selectivity. This minimizes undesired by-products and enhances overall process value, offering significant environmental and economic benefits.
Technical specifications
- Catalyst Composition: Non-toxic multi-metallic nanoceramics
- Support Structure: Functional matrix for enhanced stability and regeneration
- Durability: High resistance to chemically aggressive environments
- Selectivity: Tuneable to reduce undesired side products
- Upcycling Process: Focused on catalytic hydrogenolysis of HDPE into wax
- Experimental Approach: Combination of in-operando studies and computational calculations for mechanism elucidation
Technology readiness level
Currently, the technology is at TRL 4, indicating that it has been validated in a laboratory environment. Future validation steps will involve optimizing catalytic performance and product selectivity in realistic conditions, aiming to enhance the upcycling process and minimize low-value by-products.
About Queen Mary University of London
Queen Mary University of London is a comprehensive public research university within the University of London, serving a large and diverse community across campuses in East and Central London. Integration with a major NHS hospital network provides co‑located clinical and translational facilities and access to trial infrastructure and real‑world datasets. An on‑site innovation ecosystem with wet‑lab and startup space, plus proximity to the City and Tech City, connects researchers to London’s finance and digital industry clusters. Research is supported by competitive funding from UK Research and Innovation councils, the National Institute for Health and Care Research, and leading UK charities. A dedicated technology transfer company manages IP, licensing, consultancy, spinouts, and Knowledge Transfer Partnerships to streamline collaboration.
delivered to your inbox.